Upgrade to SI Premium - Free Trial

RBC Capital on Bristol-Myers Squibb's (BMY) AZN Deal Feedback

August 4, 2026 8:48 AM
RBC Capital analyst Trung Huynh reiterated a Sector Perform rating and $64.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments